Mastitis Market Research Report - Global Forecast till 2023

Mastitis Market Research Report - Global Forecast till 2023

ID: MRFR/HC/3936-HCRR | | Region: Global | 95 pages | Half-Cooked Research Reports

Mastitis Market Research Report- Types (Contagious Mastitis, Environmental Mastitis) Diagnosis (Physical Examination, Others), Treatment (Antibiotics, Pain Relievers, Surgery), End User (Hospitals & Clinics, Research Centers) - Global Forecast till 2023  


Market Scenario


Mastitis is a breast infection, which results in breast pain, swelling, warmth, and redness. In most cases, lactation mastitis occurs within the first six to 12 weeks after giving birth (postpartum), but it can happen later during the breastfeeding. The major symptoms of mastitis include breast tenderness or warmth to the touch, malaise, breast swelling, pain or a burning sensation continuously or while breastfeeding, skin redness, often in a wedge-shaped pattern, high fever and others.


According to the WHO, breast cancer is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and the number is continuously increasing. Prevalence of breast cancer is more common in developed countries as compared to developing countries. The global breast cancer market is driven by increasing number of females having breast cancer. Adoption of an unhealthy lifestyle, exposure to harmful radiation, increasing female geriatric population, and increasing government initiatives also contributed to the growth of the market. Since no absolute treatment is available to completely cure the disease, there is a scope for developing effective treatments. On another hand, the high cost of the treatment, adverse effects associated with the therapy, and long approval time for the drugs may restrain the growth of the market. However, the high cost of the treatment is likely to affect the growth of the market, negatively.


The global mastitis market is expected to grow at a CAGR of ~7.6 % during the forecast period 2017-2023.


 Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Neurological Companies

  • Hospitals and Clinics

  • Academic Institutes and Universities


Figure 1: Global Mastitis Market Share, by Region, 2016 (%)

Mastitis Market


Sources: WHO, annual reports, press release, white paper, company presentation


Segmentations


The global mastitis market is segmented on the basis of types, diagnosis, treatment, and end users.


Based on the types, the market is segmented into contagious mastitis and environmental mastitis.


On the basis of the diagnosis, the market is segmented into the physical examination and others.


On the basis of the treatment, the market is segmented into antibiotics, pain relievers, surgery, and others. The pain relievers are further segmented into acetaminophen, ibuprofen, and others. Moreover, acetaminophen is segmented into Tylenol and others. Ibuprofen is further segmented into Advil, Motrin IB, and others.


On the basis of the end users, the market is segmented into hospital & clinics, research centers, and others.


Key Players


Some of the key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (U.S.), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (U.K.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K.), Genentech (U.S.), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.


Research Methodology

Mastitis Market 2018


Sources: WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


The Americas dominate the global mastitis market owing to the increasing number of patients with various cancer such as mastitis, and rare diseases. Due to rapidly increasing patient population, governments have started supporting the manufacturers for the development of new and better drugs. Additionally, well-developed technology, high healthcare expenditure, and strong government support for research & development have fueled the growth of the market in this region.


Europe commands the second largest market for mastitis, which is followed by the Asia Pacific. Availability of funds, increasing need for better treatment options, and strong government support drive the growth of the market in Europe. Germany, France & the U.K are the major contributors to the European market growth.


The Asia Pacific is the fastest growing mastitis market owing to the increasing number of patients with cancers and the presence of a huge opportunity for the development of the market. Additionally, rapidly growing economies and increasing healthcare expenditure are likely to fuel the growth of the market over the assessment period.


On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited availability of medical facilities, and poor political conditions in Africa. The Middle East region holds the major share of the market owing to well-developed technology and high healthcare expenditure. On the other hand, African region shows the fastest growth due to the availability of opportunities for the market growth.

Table of Content



1. Report Prologue



2. Market Introduction



2.1 Definition



2.2 Scope of the Study



2.2.1 Research Objective



2.2.2 Assumptions



2.2.3 Limitations



3. Research Methodology



3.1 Introduction



3.2 Primary Research



3.3 Secondary research



3.4 Market Size Estimation



4. Market Dynamics



4.1 Drivers



4.2 Restrains



4.3 Opportunities



4.4 Challenges



4.5 Macroeconomic Indicators



4.6 Technology Trends & Assessment



5. Market Factor Analysis



5.1 Porters Five Forces Analysis



5.1.1 Bargaining Power of Suppliers



5.1.2 Bargaining Power of Buyers



5.1.3 Threat of New Entrants



5.1.4 Threat of Substitutes



5.1.5 Intensity of Rivalry



5.2 Value Chain Analysis



5.3 Investment Feasibility Analysis



5.4 Pricing Analysis



6. Global Mastitis Market, by Type



6.1 Introduction



6.2 Contagious Mastitis



6.2.1 Market Estimates & Forecast, 2017-2023



6.3 Environmental Mastitis



6.3.1 Market Estimates & Forecast, 2017-2023



7. Global Mastitis Market, by Diagnosis



7.1 Introduction



7.2 Physical Examination



7.2.1 Market Estimates & Forecast, 2017-2023



7.3 Others



7.3.1 Market Estimates & Forecast, 2017-2023



8. Global Mastitis Market, by Treatment



8.1 Introduction



8.2 Antibiotics



8.2.1 Market Estimates & Forecast, 2017-2023



8.3 Pain Relievers



8.3.1 Market Estimates & Forecast, 2017-2023



8.4 Surgery



8.4.1 Market Estimates & Forecast, 2017-2023



9. Global Mastitis Market, by End User



9.1 Introduction



9.2 Hospital & Clinics



9.2.1 Market Estimates & Forecast, 2017-2023



9.3 Research Centers



9.3.1 Market Estimates & Forecast, 2017-2023



9.3 Others



9.3.1 Market Estimates & Forecast, 2017-2023



10. Global Mastitis Market, by Region



10.1 Introduction



10.2 Americas



10.2.1 North America



10.2.1.1 US



10.2.1.1 Canada



10.2.2 South America



10.3 Europe



10.3.1 Western Europe



10.3.1.1 Germany



10.3.1.2 France



10.3.1.3 UK



10.3.1.4 Italy



10.3.1.5 Spain



10.3.1.6 Rest of Western Europe



10.3.2 Eastern Europe



10.4 Asia Pacific



10.4.1 Japan



10.4.2 China



10.4.3 India



10.4.4 Australia



10.4.5 Republic of Korea



10.4.6 Rest of Asia Pacific



10.5 The Middle East & Africa



10.5.1 United Arab Emirates



10.5.2 Saudi Arabia



10.5.3 Oman



10.5.4 Kuwait



10.5.5 Qatar



10.5.6 Rest of the Middle East & Africa



11 Company Landscape



11.1 Introduction



11.2 Market Share Analysis



11.3 Key Development & Strategies



11.3.1 Key Developments



12 Company Profiles



12.1 Pfizer



12.1.1 Company Overview



12.1.2 Product Overview



12.1.3 Financials



12.1.4 SWOT Analysis



12.2 Novartis AG



12.2.1 Company Overview



12.2.2 Product Overview



12.2.3 Financial Overview



12.2.4 Key Developments



12.2.5 SWOT Analysis



12.3 Oncogenex



12.3.1 Company Overview



12.3.2 Product Overview



12.3.3 Financial Overview



12.3.4 Key Development



12.3.5 SWOT Analysis



12.4 Apthera Inc



12.4.1 Company Overview



12.4.2 Product/Business Segment Overview



12.4.3 Financial Overview



12.4.4 Key Development



12.4.5 SWOT Analysis



12.5 BioNumerik Pharmaceuticals



12.5.1 Company Overview



12.5.2 Product Overview



12.5.3 Financial overview



12.5.4 Key Developments



12.6 Oncothyreon Inc



12.6.1 Company Overview



12.6.2 Product Overview



12.6.3 Financial Overview



12.6.4 Key Developments



12.7 Astellas



12.7.1 Overview



12.7.2 Product Overview



12.7.3 Financials



12.7.4 Key Developments



12.7.5 SWOT Analysis



12.8 Others



13 MRFR Conclusion



13.1 Key Findings



13.1.1 From CEO’s View Point



13.1.2 Unmet Needs of the Market



13.2 Key Companies to Watch



13.3 Prediction of Pharmaceutical Industry



14 Appendix





LIST OF TABLES



Table 1 Mastitis Industry Synopsis, 2017-2023



Table 2 Global Mastitis Market Estimates and Forecast, 2017-2023, (USD Million)



Table 3 Global Mastitis Market by Region, 2017-2023, (USD Million)



Table 4 Global Mastitis Market by Types, 2017-2023, (USD Million)



Table 5 Global Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 6 Global Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 7 Global Mastitis Market by End Users, 2017-2023, (USD Million)



Table 8 North America Mastitis Market by Types, 2017-2023, (USD Million)



Table 9 North America Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 10 North America Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 11 North America Mastitis Market by End Users, 2017-2023, (USD Million)



Table 12 US Mastitis Market by Types, 2017-2023, (USD Million)



Table 13 US Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 14 US Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 15 US Mastitis Market by End Users, 2017-2023, (USD Million)



Table 16 Canada Mastitis Market by Types, 2017-2023, (USD Million)



Table 17 Canada Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 18 Canada Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 19 Canada Mastitis Market by End Users, 2017-2023, (USD Million)



Table 20 South America Mastitis Market by Types, 2017-2023, (USD Million)



Table 21 South America Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 22 South America Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 23 South America Mastitis Market by End Users, 2017-2023, (USD Million)



Table 24 Europe Mastitis Market by Types, 2017-2023, (USD Million)



Table 25 Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 26 Europe Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 27 Europe Mastitis Market by End Users, 2017-2023, (USD Million)



Table 28 Western Europe Mastitis Market by Types, 2017-2023, (USD Million)



Table 29 Western Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 30 Western Europe Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 31 Western Europe Mastitis Market by End Users, 2017-2023, (USD Million)



Table 32 Eastern Europe Mastitis Market by Types, 2017-2023, (USD Million)



Table 33 Eastern Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 34 Eastern Europe Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 35 Eastern Europe Mastitis Market by End Users, 2017-2023, (USD Million)



Table 36 Asia Pacific Mastitis Market by Types, 2017-2023, (USD Million)



Table 37 Asia Pacific Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 38 Asia Pacific Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 39 Asia Pacific Mastitis Market by End Users, 2017-2023, (USD Million)



Table 40 Middle East & Africa Mastitis Market by Types, 2017-2023, (USD Million)



Table 41 Middle East & Africa Mastitis Market by Diagnosis, 2017-2023, (USD Million)



Table 42 Middle East & Africa Mastitis Market by Treatment, 2017-2023, (USD Million)



Table 43 Middle East & Africa Mastitis Market by End Users, 2017-2023, (USD Million)



LIST OF FIGURES



Figure 1 Research Process



Figure 2 Segmentation for Global Mastitis Market



Figure 3 Segmentation Market Dynamics for Mastitis Market



Figure 4 Global Mastitis Market Share, by Diagnosis 2016



Figure 5 Global Mastitis Market Share, by Treatment 2016



Figure 6 Global Mastitis Market Share, by End Users, 2016



Figure 7 Global Mastitis Market Share, by Region, 2016



Figure 8 North America Mastitis Market Share, by Country, 2016



Figure 9 Europe Mastitis Market Share, by Country, 2016



Figure 10 Asia Pacific Mastitis Market Share, by Country, 2016



Figure 11 Middle East & Africa Mastitis Market Share, by Country, 2016



Figure 12 Global Mastitis Market: Company Share Analysis, 2016 (%)



Figure 13 Pfizer: Key Financials



Figure 14 Pfizer: Segmental Revenue



Figure 16 Pfizer: Geographical Revenue



Figure 17 Novartis AG: Key Financials



Figure 18 Novartis AG: Segmental Revenue



Figure 19 Novartis AG: Geographical Revenue



Figure 20 Oncogenex: Key Financials



Figure 21 Oncogenex: Segmental Revenue



Figure 22 Oncogenex: Geographical Revenue



Figure 23 Apthera Inc: Key Financials



Figure 24 Apthera Inc: Segmental Revenue



Figure 25 Apthera Inc: Geographical Revenue



Figure 26 BioNumerik Pharmaceuticals: Key Financials



Figure 27 BioNumerik Pharmaceuticals: Segmental Revenue



Figure 28 BioNumerik Pharmaceuticals: Geographical Revenue



Figure 29 Oncothyreon Inc: Key Financials



Figure 30 Oncothyreon Inc: Segmental Revenue



Figure 31 Oncothyreon Inc: Geographical Revenue



Figure 32 Astellas: Key Financials



Figure 33 Astellas: Segmental Revenue



Figure 34 Astellas: Geographical Revenue